Order Center
 
Gene and Product Information 
CBLL1 
Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1
 
Properties
Official Symbol 
 
Species 
Homo sapiens
 
Entrez Gene ID 
 
Alternate Symbol 
CBLL1; FLJ23109; HAKAI; MGC163401; MGC163403; RNF188
 
Other Designations 
Casitas B-lineage lymphoma-like; E-cadherin binding protein E7
 
Refseq ID(s) 
 
Accession No.(s) 
 
Protein ID(s) 
 
Homolog(s) 
 
Function(s) 
cell adhesion; protein binding; ubiquitin pathway
 
Available Product(s) 

 
Related Products
Type
Description
SHGLY-NM_024814 MISSION® shRNA Bacterial Glycerol Stock
SHVRS-NM_024814 MISSION® shRNA Lentiviral Transduction Particles
SHDNA-NM_024814 MISSION® shRNA Plasmid DNA

Product #
Description
SI00100 MISSION® siRNA Human Druggable Genome Library 6650 targets
SI01100 MISSION® siRNA Human Gene Family Panels Ligase Panel, 949 targets

 
 siRNA

siRNA ID
RefSeq ID
Approx. siRNA Start
siRNA Type
Ranking
SASI_Hs01_00020900 NM_024814 919 MISSION® siRNA 1
SASI_Hs01_00020901 NM_024814 579 MISSION® siRNA 2
SASI_Hs01_00020902 NM_024814 1595 MISSION® siRNA 3
SASI_Hs01_00020903 NM_024814 1119 MISSION® siRNA 4
SASI_Hs01_00020904 NM_024814 669 MISSION® siRNA 5
SASI_Hs01_00020905 NM_024814 564 MISSION® siRNA 6
SASI_Hs01_00020906 NM_024814 766 MISSION® siRNA 7
SASI_Hs01_00020907 NM_024814 913 MISSION® siRNA 8
SASI_Hs01_00020908 NM_024814 1380 MISSION® siRNA 9
SASI_Hs01_00020909 NM_024814 1474 MISSION® siRNA 10
Sigma's MISSION® siRNA have been designed using a world-class siRNA design algorithm licensed from Rosetta Inpharmatics, a leader in advanced siRNA research. Critical rules incorporated into the best-in-class Rosetta siRNA design algorithm lead to siRNA of increased target specificity and knockdown for low abundance messages.


 Site Use Terms | Terms and Conditions of Sale | Privacy |
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.